{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:03:13Z","timestamp":1773270193156,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00520-026-10414-6","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T01:34:10Z","timestamp":1771292050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"34","author":[{"given":"Emily J.","family":"Mason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy M.","family":"Schraw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Woodhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Monica","family":"Gramatges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa B.","family":"Harrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen R.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna S.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Mittelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etan","family":"Orgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"11","key":"10414_CR1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/jnci\/djad115","volume":"115","author":"DA Siegel","year":"2023","unstructured":"Siegel DA, King JB, Lupo PJ et al (2023) Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. J Natl Cancer Inst 115(11):1337\u20131354. https:\/\/doi.org\/10.1093\/jnci\/djad115","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10414_CR2","first-page":"3461","volume":"11","author":"TW Mudd","year":"2021","unstructured":"Mudd TW, Guddati AK (2021) Management of hepatotoxicity of chemotherapy and targeted agents. Am J Cancer Res 11(7):3461\u20133474","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10414_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.seminoncol.2005.11.002","volume":"33","author":"J Floyd","year":"2006","unstructured":"Floyd J, Mirza I, Sachs B, Perry MC (2006) Hepatotoxicity of chemotherapy. Semin Oncol 33(1):50\u201367. https:\/\/doi.org\/10.1053\/j.seminoncol.2005.11.002","journal-title":"Semin Oncol"},{"issue":"5","key":"10414_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3324\/haematol.2021.279805","volume":"107","author":"JS Yi","year":"2022","unstructured":"Yi JS, Chambers TM, Getz KD et al (2022) A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment. Haematologica 107(5):1185\u20131188. https:\/\/doi.org\/10.3324\/haematol.2021.279805","journal-title":"Haematologica"},{"issue":"2","key":"10414_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27515","volume":"66","author":"CK Meenan","year":"2019","unstructured":"Meenan CK, Kelly JA, Wang L, Ritchey AK, Maurer SH (2019) Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy. Pediatr Blood Cancer 66(2):e27515. https:\/\/doi.org\/10.1002\/pbc.27515","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10414_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28063","volume":"67","author":"SK Hashmi","year":"2020","unstructured":"Hashmi SK, Navai SA, Chambers TM et al (2020) Incidence and predictors of treatment-related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia. Pediatr Blood Cancer 67(2):e28063. https:\/\/doi.org\/10.1002\/pbc.28063","journal-title":"Pediatr Blood Cancer"},{"key":"10414_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26891","author":"CC Denton","year":"2018","unstructured":"Denton CC, Rawlins YA, Oberley MJ, Bhojwani D, Orgel E (2018) Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26891","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10414_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0366-3","volume":"19","author":"H Ren","year":"2019","unstructured":"Ren H, Wang J, Gao Y, Yang F, Huang W (2019) Metabolic syndrome and liver-related events: a systematic review and meta-analysis. BMC Endocr Disord 19(1):40. https:\/\/doi.org\/10.1186\/s12902-019-0366-3","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"10414_CR9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/ijc.30818","volume":"141","author":"P Nderitu","year":"2017","unstructured":"Nderitu P, Bosco C, Garmo H et al (2017) The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: a study in the Swedish AMORIS cohort. Int J Cancer 141(6):1148\u20131160. https:\/\/doi.org\/10.1002\/ijc.30818","journal-title":"Int J Cancer"},{"issue":"7","key":"10414_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/CS20080253","volume":"116","author":"CD Byrne","year":"2009","unstructured":"Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH (2009) Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 116(7):539\u2013564. https:\/\/doi.org\/10.1042\/CS20080253","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10414_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2337\/dc17-1318","volume":"41","author":"M Apostolopoulou","year":"2018","unstructured":"Apostolopoulou M, Gordillo R, Koliaki C et al (2018) Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis. Diabetes Care 41(6):1235\u20131243. https:\/\/doi.org\/10.2337\/dc17-1318","journal-title":"Diabetes Care"},{"issue":"5","key":"10414_CR12","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jhep.2021.06.043","volume":"75","author":"J Claria","year":"2021","unstructured":"Claria J, Curto A, Moreau R et al (2021) Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis. J Hepatol 75(5):1116\u20131127. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.043","journal-title":"J Hepatol"},{"issue":"1","key":"10414_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01526-5","volume":"20","author":"YN Flores","year":"2021","unstructured":"Flores YN, Amoon AT, Su B et al (2021) Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico. Lipids Health Dis 20(1):136. https:\/\/doi.org\/10.1186\/s12944-021-01526-5","journal-title":"Lipids Health Dis"},{"key":"10414_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612717","author":"G Kalopitas","year":"2023","unstructured":"Kalopitas G, Mouskeftara T, Liapikos T et al (2023) Plasma lipids profile in the prediction of non-alcoholic steatohepatitis in adults: a case-control study. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241612717","journal-title":"Int J Mol Sci"},{"key":"10414_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/nu10050649","author":"S Tiwari-Heckler","year":"2018","unstructured":"Tiwari-Heckler S, Gan-Schreier H, Stremmel W, Chamulitrat W, Pathil A (2018) Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors. Nutrients. https:\/\/doi.org\/10.3390\/nu10050649","journal-title":"Nutrients"},{"key":"10414_CR16","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016978","author":"EJ Mason","year":"2025","unstructured":"Mason EJ, Crain AM, Scheurer ME et al (2025) An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2025016978","journal-title":"Blood Adv"},{"key":"10414_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1235160","volume":"10","author":"C Arevalo","year":"2023","unstructured":"Arevalo C, Rojas L, Santamaria M et al (2023) Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients. Front Mol Biosci 10:1235160. https:\/\/doi.org\/10.3389\/fmolb.2023.1235160","journal-title":"Front Mol Biosci"},{"key":"10414_CR18","unstructured":"National Institutes of Health (NIH) (2015) Racial and ethnic categories and definitions for NIH diversity programs and for other reporting purposes. https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-OD-15-089.html"},{"key":"10414_CR19","unstructured":"Statistics NCfH. Growth Charts. CDC. 2025. https:\/\/www.cdc.gov\/growthcharts\/index.html. Accessed 2 Sept 2024"},{"key":"10414_CR20","unstructured":"Lipidomics U. SHOTGUN LIPIDOMICS\u00a0UCLA. 2024. https:\/\/www.uclalipidomics.net\/services.html.\u00a0Accessed 2 Sept 2024"},{"issue":"11","key":"10414_CR21","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1021\/jasms.1c00203","volume":"32","author":"B Su","year":"2021","unstructured":"Su B, Bettcher LF, Hsieh WY et al (2021) A DMS shotgun lipidomics workflow application to facilitate high-throughput, comprehensive lipidomics. J Am Soc Mass Spectrom 32(11):2655\u20132663. https:\/\/doi.org\/10.1021\/jasms.1c00203","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"10414_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100235","volume":"2","author":"WY Hsieh","year":"2021","unstructured":"Hsieh WY, Williams KJ, Su B, Bensinger SJ (2021) Profiling of mouse macrophage lipidome using direct infusion shotgun mass spectrometry. STAR Protoc 2(1):100235. https:\/\/doi.org\/10.1016\/j.xpro.2020.100235","journal-title":"STAR Protoc"},{"issue":"15","key":"10414_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202300606","volume":"24","author":"N Frolich","year":"2024","unstructured":"Frolich N, Klose C, Widen E, Ripatti S, Gerl MJ (2024) Imputation of missing values in lipidomic datasets. Proteomics 24(15):e2300606. https:\/\/doi.org\/10.1002\/pmic.202300606","journal-title":"Proteomics"},{"issue":"1","key":"10414_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-19120-0","volume":"8","author":"R Wei","year":"2018","unstructured":"Wei R, Wang J, Su M et al (2018) Missing value imputation approach for mass spectrometry-based metabolomics data. Sci Rep 8(1):663. https:\/\/doi.org\/10.1038\/s41598-017-19120-0","journal-title":"Sci Rep"},{"issue":"3","key":"10414_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1109\/TIP.2010.2071390","volume":"20","author":"G Cao","year":"2011","unstructured":"Cao G, Bachega LR, Bouman CA (2011) The sparse matrix transform for covariance estimation and analysis of high dimensional signals. IEEE Trans Image Process 20(3):625\u2013640. https:\/\/doi.org\/10.1109\/TIP.2010.2071390","journal-title":"IEEE Trans Image Process"},{"issue":"Suppl 1","key":"10414_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-3310-7","volume":"21","author":"D Ruiz-Perez","year":"2020","unstructured":"Ruiz-Perez D, Guan H, Madhivanan P, Mathee K, Narasimhan G (2020) So you think you can PLS-DA? BMC Bioinformatics 21(Suppl 1):2. https:\/\/doi.org\/10.1186\/s12859-019-3310-7","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"10414_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/sim.7986","volume":"38","author":"H Xu","year":"2019","unstructured":"Xu H, Qian J, Paynter NP et al (2019) Estimating the receiver operating characteristic curve in matched case control studies. Stat Med 38(3):437\u2013451. https:\/\/doi.org\/10.1002\/sim.7986","journal-title":"Stat Med"},{"issue":"8","key":"10414_CR28","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1016\/j.clnu.2021.06.006","volume":"40","author":"M Prada","year":"2021","unstructured":"Prada M, Wittenbecher C, Eichelmann F, Wernitz A, Drouin-Chartier JP, Schulze MB (2021) Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: a targeted analysis of lipidomics data in the EPIC-Potsdam cohort. Clin Nutr 40(8):4988\u20134999. https:\/\/doi.org\/10.1016\/j.clnu.2021.06.006","journal-title":"Clin Nutr"},{"issue":"1","key":"10414_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/ijbs.78525","volume":"19","author":"C Zhu","year":"2023","unstructured":"Zhu C, Huai Q, Zhang X, Dai H, Li X, Wang H (2023) Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease. Int J Biol Sci 19(1):311\u2013330. https:\/\/doi.org\/10.7150\/ijbs.78525","journal-title":"Int J Biol Sci"},{"key":"10414_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.677202","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Hu Y, An Y, Wang Q, Liu J, Wang G (2022) The changes of lipidomic profiles reveal therapeutic effects of exenatide in patients with type 2 diabetes. Front Endocrinol (Lausanne) 13:677202. https:\/\/doi.org\/10.3389\/fendo.2022.677202","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10414_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/nutrit\/nuy048","volume":"77","author":"IG Pranger","year":"2019","unstructured":"Pranger IG, Joustra ML, Corpeleijn E et al (2019) Fatty acids as biomarkers of total dairy and dairy fat intakes: a systematic review and meta-analysis. Nutr Rev 77(1):46\u201363. https:\/\/doi.org\/10.1093\/nutrit\/nuy048","journal-title":"Nutr Rev"},{"issue":"5","key":"10414_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.diabet.2016.12.008","volume":"43","author":"M Al-Majdoub","year":"2017","unstructured":"Al-Majdoub M, Geidenstam N, Ali A et al (2017) Branched-chain amino acids are associated with odd-chain fatty acids in normoglycaemic individuals. Diabetes Metab 43(5):475\u2013479. https:\/\/doi.org\/10.1016\/j.diabet.2016.12.008","journal-title":"Diabetes Metab"},{"key":"10414_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145850","author":"SB Crown","year":"2015","unstructured":"Crown SB, Marze N, Antoniewicz MR (2015) Catabolism of branched chain amino acids contributes significantly to synthesis of odd-chain and even-chain fatty acids in 3T3-L1 adipocytes. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0145850","journal-title":"PLoS One"},{"key":"10414_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu16121875","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhan L, Zhang L, Shi Q, Li L (2024) Branched-chain amino acids in liver diseases: complexity and controversy. Nutrients. https:\/\/doi.org\/10.3390\/nu16121875","journal-title":"Nutrients"},{"key":"10414_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12739","author":"J Lischka","year":"2021","unstructured":"Lischka J, Schanzer A, Hojreh A et al (2021) A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity. Pediatr Obes. https:\/\/doi.org\/10.1111\/ijpo.12739","journal-title":"Pediatr Obes"},{"key":"10414_CR36","doi-asserted-by":"publisher","unstructured":"Sharma N, Pandey S, Tripathi G, et al. Plasma lipidomics and fungal peptide-based community analysis identifies distinct signatures of early mortality in acute liver failure. Clin Mol Hepatol. 2024;https:\/\/doi.org\/10.3350\/cmh.2024.0554","DOI":"10.3350\/cmh.2024.0554"},{"key":"10414_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0758-5","author":"Y Kawano","year":"2013","unstructured":"Kawano Y, Cohen DE (2013) Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol. https:\/\/doi.org\/10.1007\/s00535-013-0758-5","journal-title":"J Gastroenterol"},{"issue":"1","key":"10414_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cphy.c170012","volume":"1","author":"M Alves-Bezerra","year":"2017","unstructured":"Alves-Bezerra M, Cohen DE (2017) Triglyceride metabolism in the liver. Compr Physiol 1(1):1\u20138. https:\/\/doi.org\/10.1002\/cphy.c170012","journal-title":"Compr Physiol"},{"key":"10414_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13216","author":"ZG Jiang","year":"2015","unstructured":"Jiang ZG, Tsugawa Y, Tapper EB et al (2015) Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States. Aliment Pharmacol Ther. https:\/\/doi.org\/10.1111\/apt.13216","journal-title":"Aliment Pharmacol Ther"},{"key":"10414_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039362","author":"CN Palmer","year":"2012","unstructured":"Palmer CN, Maglio C, Pirazzi C et al (2012) Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0039362","journal-title":"PLoS One"},{"issue":"1","key":"10414_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49224-x","volume":"15","author":"SM Johnson","year":"2024","unstructured":"Johnson SM, Bao H, McMahon CE et al (2024) PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein. Nat Commun 15(1):4847. https:\/\/doi.org\/10.1038\/s41467-024-49224-x","journal-title":"Nat Commun"},{"issue":"12","key":"10414_CR42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.48803","volume":"5","author":"W Yang","year":"2022","unstructured":"Yang W, Karol SE, Hoshitsuki K et al (2022) Association of inherited genetic factors with drug-induced hepatic damage among children with acute lymphoblastic leukemia. JAMA Netw Open 5(12):e2248803. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.48803","journal-title":"JAMA Netw Open"},{"key":"10414_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.629","author":"Y Liu","year":"2017","unstructured":"Liu Y, Fernandez CA, Smith C et al (2017) Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy. Clin Pharmacol Ther. https:\/\/doi.org\/10.1002\/cpt.629","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10414_CR44","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1016\/S2352-3026(22)00168-5","volume":"9","author":"TP Miller","year":"2022","unstructured":"Miller TP, Getz KD, Li Y et al (2022) Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children\u2019s Oncology Group. Lancet Haematol 9(9):e678\u2013e688. https:\/\/doi.org\/10.1016\/S2352-3026(22)00168-5","journal-title":"Lancet Haematol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10414-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:45:43Z","timestamp":1773215143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10414"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10414-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}